$2 and $1 targets... Yucky wouldn't touch it with yours, page-429

Another disappointing day for RAC SH's with the SP hitting an all time 12 month low today.

I am not seeing anything from the Q&A presentation last night that will address this decline in the SP.
Maybe the Sheba trial results in December but that is 3 months away. Plenty of time to buy back in at a lower SP.

As a share for over 2.5 years (buy in avg of $2.52) i must say i am missing the way the business operated around releasing new testing and trial results. You could not predict when news was coming, there was that fomo. With this new approach the fomo no longer exists and SH are getting impatient and selling knowing that they can buy back in a couple of months time at a lower SP before results are published.

I understand the reasoning for the change of how this will be communicated going forward but I am not totally convinced that it needs to be firstly released in the medical journal prior to ASX announcement.

If results are released to the public prior to medical journal then it will not get published in medical journal. But if results are released via an ASX announcement and these results are ground breaking news in the oncology space, surely big pharma would hear of this news through other media channels and take an interest?
Or is the releasing of results via the ASX announcement raining on the Professors work?